Alertes de seguretat de fàrmacs
10.5K views | +1 today
Follow
 
Scooped by CedimCat
onto Alertes de seguretat de fàrmacs
Scoop.it!

Proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth

The use of proton pump inhibitors (PPIs) may potentially predispose to the development of small intestinal bacterial overgrowth (SIBO), but this association is controversial

more...
No comment yet.
Alertes de seguretat de fàrmacs
Monitorització d'alertes de seguretat de fàrmacs. Seguretat clínica a recepta electrònica. Centre d'Informació de Medicaments de Catalunya (CedimCat) http://www.cedimcat.info
Curated by CedimCat
Your new post is loading...
Your new post is loading...
Scooped by CedimCat
Scoop.it!

Hidroclorotiazida (uso continuo y prolongado) y riesgo de cáncer cutáneo no melanocítico

"Hidroclorotiazida: el uso continuo y prolongado en el tiempo podría aumentar el riesgo de cáncer cutáneo no melanocítico."

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Bezlotoxumab (Zinplava°) & recurrence of C. difficile infection and cardiotoxicity

"In patients undergoing antibiotic therapy for an episode of Clostridium difficile infection, the addition of a single infusion of bezlotoxumab reduces the risk of recurrence of C. difficile-associated diarrhoea within 3 months from about 27% with placebo to about 16%. Bezlotoxumab has not been properly evaluated in patients at high risk of recurrence. It increases the risk of heart failure."

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Inhibiteurs de la pompe à protons: éviter leur utilisation à long terme''

"Les inhibiteurs de la pompe à protons (IPP) tels que l'oméprazole ont des effets indésirables graves à long terme qui incitent à ne pas banaliser leur utilisation et à éviter leur utilisation à long terme."

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Atezolizumab ( Tecentriq®) and risk of immune-related nephritis

Cases of immune-related nephritis have been reported in cancer patients receiving TECENTRIQ treatment. As of 31 May 2018, there were a total of 28 cases including 13 biopsy confirmed cases in which atezolizumab played a potential role in the development of nephritis.
more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Lenalidomide and increased risk of ischemic stroke in multiple myeloma

Clin Neuropharmacol. 2018 doi: 10.1097/WNF.0000000000000310. [Epub ahead of print]

A case report and review of the literature

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Hidroxietil-almidón y insuficiencia renal - mortalidad

Soluciones de hidroxietil-almidón: conclusiones de la revisión realizada. Acceso controlado y obligación de seguir estrictamente las condiciones de uso autorizadas

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

SGLT2 inhibitors and risk of acute and chronic pancreatitis

SGLT2 inhibitors (canagliflozin, dapagliflozin and empagliflozin)

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Concurrent use of warfarin and other medications in high-risk elderly and bleeding events

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Valproato y riesgos de malformaciones congénitas y trastornos del neurodesarrollo en la descendencia - programa de prevención de embarazos

Valproato (▼Depakine / ▼Depakine Crono) y riesgos de malformaciones congénitas/trastornos del neurodesarrollo en la descendencia - programa de prevención de embarazos

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Insulina i major risc de fractures en pacients amb Diabetis Tipus 2

Investigadors del CIBERFES i del CIBERDEM, entre ells el Dr. Dídac Mauricio, director de Servei d’Endocrinologia de Sant Pau, han relacionat l'ús dels tractaments amb insulina amb un augment del risc de fractures entre els pacients amb Diabetis Mellitus tipus 2 (DM2). Publicat a la revista Osteoporosis International.

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Infliximab an increased risk of serious infection in patients with psoriasis

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Domperidone in Parkinson's patients and increased risk of all‐cause mortality associated

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Fluoroquinolone and quinolone and disabling, potentially long-lasting side effects: restrictions on use

Press release 05/10/2018

"EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended restricting the use of fluoroquinolone and quinolone antibiotics (used by mouth, injection or inhalation) following a review of disabling and potentially long-lasting side effects reported with these medicines."

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Brivudina y f-fluoropirimidinas interacción potencialmente mortal title

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia

Objective To evaluate whether oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin increase the risk of ventricular arrhythmia in Korea’s general population.

Design Population-based cohort study using administrative claims data on a national scale in Korea.
more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Daclizumab beta (Zinbryta▼) and risk of immune-mediated encephalitis – some cases several months after stopping treatment

Monitoring for encephalitis should continue for 12 months following discontinuation of daclizumab. Inform all patients who have discontinued daclizumab and their caregivers of the common symptoms of encephalitis and the need to contact their doctor immediately if they occur.
more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Alertes de seguretat de fàrmacs - Newsletter 49 (Agost 2018)

CedimCat http://www.cedimcat.info

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Esmya (ulipristal acetate) and risk of serious liver injury

More than one treatment course is authorised only in women who are not eligible for surgery, and liver function monitoring is to be carried out in all women treated with Esmya. Before initiation, discuss with women the rare risk of liver damage and advise them to seek urgent medical attention if...
more...
No comment yet.
Scooped by CedimCat
Scoop.it!

SGLT2 Inhibitors for diabetes and rare occurrences of a serious infection of the genital area

Requiring a new warning about this risk to be added to the prescribing information of all SGLT2 inhibitors and to the patient Medication Guide.
more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Proton Pump Inhibitor in older adults: long-term risks (acute interstitial nephritis, fractures, and Clostridium difficile-associated diarrhea)

Proton pump inhibitors (PPIs) are commonly prescribed for treatment of acid-related gastrointestinal disorders. PPI use is approved for a duration of 2 to 12 weeks, depending on complication and severity. Many users lack an appropriate indication for continued therapy past the recommended duration.

more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Esmya (acetato de ulipristal) y riesgo de daño hepático

Esmya (acetato de ulipristal): restricciones de uso y nuevas medidas adoptadas para minimizar el riesgo de daño hepático
more...
No comment yet.
Scooped by CedimCat
Scoop.it!

Fentanilo y riesgo de hiperalgesia

En publicaciones recientes se han descrito casos notificados de hiperalgesia en pacientes tratados con fentanilo por vía transmucosa oral.

more...
No comment yet.